Starpharma gets New Zealand marketing clearance for VivaGel condom

/in /by

THE ROADHOUSE PHARMACY: Starpharma Holdings (ASX: SPL) has completed regulatory requirements to allow for marketing of the VivaGel® condom in New Zealand under the brand Lifestyles® Dual Protect™.

Starpharma’s commercial partner, Ansell, along with its New Zealand distributor, EBOS Group, plan to launch the Lifestyles Dual Protect condom in the New Year having obtained market clearance for New Zealand.

Dual Protect with VivaGel is the world’s first antiviral condom.

“We are very pleased to announce this next approval of the VivaGel condom for marketing, and look forward to further regulatory acceptances and launches of the product in other regions in the future,” Starpharma Holdings CEO Dr Jackie Fairley said in the company’s announcement to the Australian Securities Exchange.

Website: www.starpharma.com